Somany Ceramics (531548) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
7 Sep, 2026Executive summary
Sales grew by up to 5.1% in Q3 FY25 despite weak domestic and export demand, reflecting operational resilience and outperforming previous quarters.
Operating margins were maintained at 8.4%, with gross margins improving and capacity utilization rising above 80%.
Strategic divestment of two joint ventures and expansion into construction chemicals through investment in Dura Build Care Private Limited.
Distribution network expanded by 134 net dealers and 46 showrooms over nine months.
Government policy changes and urbanization initiatives expected to support industry growth.
Financial highlights
Consolidated sales rose 5.1% year-over-year to ₹640 crore in Q3 FY25; standalone sales grew 4% to ₹621 crore.
Operating margin held at 8.4%, down from 9.7% year-over-year but stable sequentially.
PAT declined 58.7% year-over-year to ₹10 crore in Q3; standalone PAT up 9.5% to ₹23 crore.
Exceptional gain of INR 9.42 crore from JV disinvestment; exceptional items included both gains and losses from subsidiary divestments.
Net debt-equity ratio reduced to 0.33 as of Dec'24; asset turnover at 2.3x.
Outlook and guidance
Guidance for mid- to high single-digit growth; Q4 expected to be slightly better with green shoots visible.
Strategic investments in construction chemicals and operational efficiency to drive future growth.
FY25 and FY26 volume growth projected at high single digits to low double digits.
Anticipates positive impact from government initiatives on disposable income and housing demand.
Latest events from Somany Ceramics
- Margin expansion and growth driven by premiumization, capacity upgrades, and bathware focus.531548
Investor presentation - Flat Q1 sales and margins, but double-digit growth targeted as demand recovers in H2.531548
Q1 24/25 - Q2 FY25 sales rose 1.4% to INR 662 crores, but PAT fell 41.2% amid muted demand.531548
Q2 24/25 - Q4 FY25 delivered 5% sales growth, margin resilience, and strategic expansion despite profit decline.531548
Q4 24/25 - Q1 sales up 4.4% YoY, margin pressure persists, but investments support future growth.531548
Q1 25/26 - Q2 revenue up 3.6% YoY, consolidated PAT down 29%, margin improvement and synergies targeted.531548
Q2 25/26 - Q3 revenue rose 6% with margin gains, higher PAT, and new HR and Labour Code provisions.531548
Q3 25/26 - FY26 saw margin expansion, strong cash flow, and strategic investment despite input cost risks.531548
Q4 25/26 - Q1 FY27 revenue up 24% YoY, EBITDA margin at 11.6%, PAT up 365.7%, outlook positive.531548
Q1 26/27